NXTS ▲ +5.8% - Nexentis Technologies Inc.
$NXTS - Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage
26-OCT-2026 08:16 AM ET
Share this post
More filings for $NXTS
NXTS ▲ +27.3% - Nexentis Technologies Inc.Oct 7, 2026NXTS ▲ +16.5% - Nexentis Technologies Inc.Sep 24, 2026NXTS ▲ +10.6% - Nexentis Technologies Inc.Sep 23, 2026$NXTS SEC Filing Update (15-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 15, 2026
View full $NXTS filing history →💬 Comments
Loading comments…
Leave a comment